Immunogenicity of YF 17D recombinant viruses or viral formulations in A/J mice.
- Raquel Tayar Nogueira (391637)
- Alanderson Rocha Nogueira (391638)
- Mirian Claudia Souza Pereira (391639)
- Maurício Martins Rodrigues (170063)
- Patrícia Cristina da Costa Neves (391640)
- Ricardo Galler (37871)
- Myrna Cristina Bonaldo (391641)
Publication date
March 2013
DOIAbstract
a<p>50% of YF17D/ENS1/Tc and 50% of YF17D/NS2B3/Tc viruses.</p>b<p>75% of YF17D/ENS1/Tc and 25% of YF17D/NS2B3/Tc viruses.</p>*<p>values indicate the reciprocal of the dilution yielding 50%. PRNT, Plaque Reduction Neutralization Test; GMT, Geometric Mean Titre.</p>**<p>differences in the titers of neutralizing antibodies virus between YF 17DD and the recombinant viruses or viral formulations were statistically significant (<i>P</i> value <0.05; Kruskal-Wallis test).</p
Add to ORKG